Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4‐hydroxy‐3, 5‐dimethoxy benzaldehyde motif. Issue 4 (27th December 2022)

• Record Type: Journal Article
• Authors: Demir, Yeliz; Türkeş, Cüneyt; Çavuş, Muhammet S.; Erdoğan, Musa; Muğlu, Halit; Yakan, Hasan; Beydemir, Şükrü
• Is Part Of: Archiv der Pharmazie. Volume 356:Issue 4(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-12-27
• Subjects: DFT -- enzyme inhibition -- molecular docking -- spectroscopic elucidation -- thiosemicarbazones; Pharmaceutical chemistry -- Periodicals; Pharmacology -- Periodicals; 615.19
• DOI: 10.1002/ardp.202200554
• Languages: English
• ISSNs: 0365-6233

Abstract

Abstract: New Schiff base‐bearing thiosemicarbazones (1–13 ) were obtained from 4‐hydroxy‐3, 5‐dimethoxy benzaldehyde and various isocyanates. The structures of the synthesized molecules were elucidated in detail. Density functional theory calculations were also performed to determine the spectroscopic properties of the compounds. Moreover, the enzyme inhibition activities of these compounds were investigated. They showed highly potent inhibition effects on acetylcholinesterase (AChE) and human carbonic anhydrases ( h CAs) ( K I values are in the range of 51.11 ± 6.01 to 278.10 ± 40.55 nM, 60.32 ± 9.78 to 300.00 ± 77.41 nM, and 64.21 ± 9.99 to 307.70 ± 61.35 nM for AChE, h CA I, and h CA II, respectively). In addition, molecular docking studies were performed, confirmed by binding affinities studies of the most potent derivatives. Abstract : Thirteen new Schiff base‐bearing thiosemicarbazones (1–13 ) were obtained from 4‐hydroxy‐3, 5‐dimethoxy benzaldehyde and various isocyanates. The structures of the synthesized molecules were elucidated in detail. Compounds 1–13 showed highly potent inhibition effects on acetylcholinesterase and human carbonic anhydrases.